BOT 6.58% 40.5¢ botanix pharmaceuticals ltd

Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-166

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,652 Posts.
    lightbulb Created with Sketch. 618
    yeah but if the end points were not met the share price of, this stock would have easily gone half or even down to 80% as we have seen after the failure of the previous trial results.

    Now we have achieved the end points and the trial is success why the opposite is not happening. It is a Bio Tech stock FFS , not a gold explorer, the share price should be up atleast 100% after these results.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
40.5¢
Change
0.025(6.58%)
Mkt cap ! $734.6M
Open High Low Value Volume
38.5¢ 40.5¢ 37.5¢ $3.018M 7.647M

Buyers (Bids)

No. Vol. Price($)
4 211394 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 853 2
View Market Depth
Last trade - 16.10pm 30/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.